Literature DB >> 9543449

The Côte d'Ivoire national HIV counseling and testing program for tuberculosis patients: implementation and analysis of epidemiologic data.

L Abouya1, I M Coulibaly, S Z Wiktor, D Coulibaly, M N'kragbo, A N'gbo, H Zahui, K Touré, K Jacquemin, M San-Koffi, A Ackah, M Sassan-Morokro, C Maurice, J P Whitaker, K M De Cock, A E Greenberg.   

Abstract

OBJECTIVES: To describe the implementation of a free, voluntary and confidential HIV counseling and testing program for patients with newly diagnosed tuberculosis at the eight large outpatient tuberculosis centers in Côte d'Ivoire, and to present epidemiologic findings on participating patients.
DESIGN: HIV counseling and testing program with ongoing HIV serosurveillance.
METHODS: HIV counseling and testing services were established at the two tuberculosis centers in Abidjan in 1989 and were extended to six centers in the Côte d'Ivoire interior in the first half of 1994. Characteristics of counseled patients, acceptance rates of HIV testing, and HIV serologic results were analyzed for all eight centers from 1994 to 1996. Temporal trends in HIV seropositivity rates were examined for the two centers of Abidjan from 1989 to 1996.
RESULTS: From July 1994 through December 1996, 17 946 (91.8%) out of 19 594 patients who were counseled at the eight centers in Côte d'Ivoire consented to HIV testing, of whom 7749 (43.2%) were HIV-seropositive. The highest rates of 47.0 and 45.6% were found in the two centers in Abidjan, with rates ranging from 32.9 to 42.4% in the six centers in the interior. HIV-seropositive tuberculosis patients from each of the 50 districts in Côte d'Ivoire were identified. In Abidjan, the HIV seropositivity rate remained relatively stable among men (46.7% in 1989, 48.5% in 1991, 43.6% in 1996), but rose sharply among women from 32.7% in 1989 to 50.1% in 1996.
CONCLUSIONS: The high HIV seropositivity rates among tuberculosis patients in all geographic regions of Côte d'Ivoire indicate that the HIV epidemic has now spread throughout the country. However, the successful implementation of an extensive HIV counseling and testing program for more than 37000 tuberculosis patients to date demonstrates the commitment of the Côte d'Ivoire Ministry of Health to integrating HIV/AIDS prevention activities with tuberculosis control efforts. When logistically and economically feasible, the extension of HIV-related social and clinical services to HIV-seropositive tuberculosis patients should be considered by other national tuberculosis control programs in Africa.

Entities:  

Mesh:

Year:  1998        PMID: 9543449     DOI: 10.1097/00002030-199805000-00012

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  8 in total

1.  Elevated HIV seroprevalence and risk behavior among Ugandan TB suspects: implications for HIV testing and prevention.

Authors:  P Srikantiah; R Lin; M Walusimbi; A Okwera; H Luzze; C C Whalen; W H Boom; D V Havlir; E D Charlebois
Journal:  Int J Tuberc Lung Dis       Date:  2007-02       Impact factor: 2.373

2.  Evaluating the potential impact of the new Global Plan to Stop TB: Thailand, 2004-2005.

Authors:  Jay K Varma; Daranee Wiriyakitjar; Sriprapa Nateniyom; Amornrat Anuwatnonthakate; Patama Monkongdee; Surin Sumnapan; Somsak Akksilp; Wanchai Sattayawuthipong; Pricha Charunsuntonsri; Somsak Rienthong; Norio Yamada; Pasakorn Akarasewi; Charles D Wells; Jordan W Tappero
Journal:  Bull World Health Organ       Date:  2007-08       Impact factor: 9.408

3.  Multidrug resistance to Mycobacterium tuberculosis in a tertiary hospital.

Authors:  Aderemi Oludiran Kehinde; Felix Ariebuwa Obaseki; Oluponle Christiana Ishola; Kolo Doko Ibrahim
Journal:  J Natl Med Assoc       Date:  2007-10       Impact factor: 1.798

4.  A cluster-randomized trial of provider-initiated (opt-out) HIV counseling and testing of tuberculosis patients in South Africa.

Authors:  Diana S Pope; Andrea N Deluca; Paula Kali; Harry Hausler; Carol Sheard; Ebrahim Hoosain; Mohammad A Chaudhary; David D Celentano; Richard E Chaisson
Journal:  J Acquir Immune Defic Syndr       Date:  2008-06-01       Impact factor: 3.731

5.  Missed opportunities for diagnosis of tuberculosis and human immunodeficiency virus co-infection in Moshi, Tanzania.

Authors:  A C Tribble; C D Hamilton; J A Crump; A Mgonja; A Mtalo; E Ndanu; D K Itemba; K Z Landman; M Shorter; E M Ndosi; J F Shao; J A Bartlett; N M Thielman
Journal:  Int J Tuberc Lung Dis       Date:  2009-10       Impact factor: 2.373

6.  Tuberculosis-HIV co-infection in Kiev City, Ukraine.

Authors:  Marieke J van der Werf; Olga B Yegorova; Nelly Chentsova; Yuriy Chechulin; Epco Hasker; Vasyl I Petrenko; Jaap Veen; Leonid V Turchenko
Journal:  Emerg Infect Dis       Date:  2006-05       Impact factor: 6.883

7.  Antiretroviral therapy during tuberculosis treatment and marked reduction in death rate of HIV-infected patients, Thailand.

Authors:  Somsak Akksilp; Opart Karnkawinpong; Wanpen Wattanaamornkiat; Daranee Viriyakitja; Patama Monkongdee; Walya Sitti; Dhanida Rienthong; Taweesap Siraprapasiri; Charles D Wells; Jordan W Tappero; Jay K Varma
Journal:  Emerg Infect Dis       Date:  2007-07       Impact factor: 6.883

8.  Dual Simian Foamy Virus/Human Immunodeficiency Virus Type 1 Infections in Persons from Côte d'Ivoire.

Authors:  William M Switzer; Shaohua Tang; HaoQiang Zheng; Anupama Shankar; Patrick S Sprinkle; Vickie Sullivan; Timothy C Granade; Walid Heneine
Journal:  PLoS One       Date:  2016-06-16       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.